The efficacy of electroacupuncture combined with Micro-Needle-Knife for allergic rhinitis: study protocol for a randomized controlled trial

Pengfei Qiu, Xue Wu, Ning Ye, Xiaofang Zhou, Jianfang Zhu, Xiayang ZengFrontiers in Medicine 2026 · DOI

TL;DR

This paper outlines a randomized controlled trial protocol to investigate the efficacy and safety of a novel combination therapy: electroacupuncture (EA) and Micro-Needle-Knife (MNK) for moderate-to-severe allergic rhinitis (AR). The study aims to provide evidence for a potentially more convenient, cost-effective, and less side-effect-prone treatment option compared to conventional Western medicine.

What Problem Does This Paper Address?

Allergic rhinitis (AR) is a widespread condition that significantly impacts quality of life, particularly in its moderate-to-severe forms. Current treatments, while offering some relief, often involve long-term medication with potential side effects and economic burdens, and a substantial portion of patients experience suboptimal outcomes or are interested in alternative therapies. Existing alternative approaches like acupuncture show promise but lack robust evidence. This study addresses the need for rigorously tested, effective, and patient-friendly treatments for AR, specifically exploring the combination of EA and MNK, which has shown potential in preliminary clinical observations but lacks formal scientific validation.

Methods

This study employs a randomized, patient-assessor-blinded, parallel-arm controlled trial.

  • Participants: 90 eligible adults with moderate-to-severe AR will be recruited.
  • Intervention Groups: Participants will be randomly assigned in a 1:1 ratio to either:
  • EA combined with Micro-Needle-Knife (MNK) group: This group will receive a 4-week treatment regimen.
  • Drug group: This group will receive conventional pharmacotherapy (cetirizine hydrochloride tablets and budesonide nasal spray) as a comparator.
  • Treatment Protocol:
    • EA Operation: Involves stimulating specific acupoints (Yingxiang LI20 and Shangyingxiang EX-HN8) with electroacupuncture for 30 minutes per session, three times a week for 4 weeks.
  • Micro-Needle-Knife Operation: Involves using MNK to release tension at specific acupoints in the occipital-cervical and cervicothoracic regions, with weekly treatments for 4 weeks.
  • Evaluation Schedule: Assessments will occur at baseline (week 0), during the intervention (weeks 2 and 4), and during follow-up (weeks 8 and 16).
  • Blinding: While the practitioners administering the treatments cannot be blinded due to the nature of the intervention, participants and outcome evaluators will be blinded. A rigorous system of allocation concealment and separation of roles (investigator, therapist, evaluator) is described.

Datasets

Not discussed in the paper. This is a study protocol, not a report of completed experiments with datasets.

Key Insights and Ideas

  • Synergistic Potential of EA and MNK: The paper posits that combining EA and MNK could offer a more effective and convenient treatment for AR than either modality alone, addressing limitations like slow onset, prolonged treatment duration, and patient discomfort associated with traditional acupuncture.
  • Focus on Moderate-to-Severe AR: By specifically targeting patients with moderate-to-severe AR, the study aims to address a population with significant unmet needs and a greater potential for improvement.
  • Multidimensional Outcome Assessment: The use of a primary outcome (TNSS) alongside several secondary outcomes (TNNSS, RQLQ, and specific biomarkers like Eotaxin, ICAM-1, ECP) provides a comprehensive evaluation of treatment efficacy, encompassing symptom relief, quality of life, and potential immunomodulatory mechanisms.
  • Addressing a Gap in Evidence: The authors highlight that despite preliminary clinical observations and the growing interest in acupuncture for AR, there is a lack of robust, randomized controlled trial evidence for the EA + MNK combination, which this study aims to fill.

Key Results

Not applicable, as this is a study protocol. The paper describes the planned methodology and expected outcomes.

Limitations and Future Work

  • Blinding Limitations: The authors acknowledge that complete blinding is not possible because the acupuncture operator must have direct contact with the patient. This is identified as a methodological limitation that could introduce bias. They plan to assess the impact of this bias and quantify the success of the blinded design through post-treatment questionnaires.
  • Convenience Disparity: The paper notes that the time commitment for acupuncture-based interventions (travel, waiting, treatment duration) can be a significant barrier to adherence for individuals with time constraints, contrasting with the convenience of home-based pharmacological treatments.
  • Future Work: The study aims to provide a basis for the clinical promotion of EA + MNK for AR, potentially leading to a standardized, effective, and easy-to-implement treatment protocol. Further research into the specific immunomodulatory mechanisms underlying the treatment is also suggested.

Summary updated

Abstract

Introduction Allergic rhinitis (AR), classified as a hypersensitivity disorder profoundly impairing human quality of life, presents substantial clinical complexities. Among these, the management of moderate-to-severe AR cases constitutes a particularly challenging clinical scenario, which seriously affects their daily life, study, sleep, and mood. The efficacy of conventional treatments for AR remains suboptimal, necessitating an urgent exploration of alternative approaches to identify simpler, more convenient, effective, and cost-efficient therapeutic options for clinical AR management. This trial is designed to rigorously assess the efficacy and safety of electroacupuncture (EA) combined with Micro-Needle-Knife therapy as a novel therapeutic modality for patients with moderate-to-severe allergic rhinitis. Methods and analysis This study protocol is a randomized controlled, patient-assessor-blinded trial. The trial will have a treatment period of 4 weeks and a follow-up period of 3 months. 90 eligible participants will be randomly assigned to the EA combined with Micro-Needle-Knife group and the drug group in a 1:1 ratio. The evaluation of all study parameters will be conducted across five distinct temporal phases: baseline assessment (week 0), two consecutive intervention phases (weeks 2 and 4), and two subsequent follow-up intervals (weeks 8 and 16). The primary outcome is the Total Nasal Symptom Score (TNSS). Secondary outcomes include Total Non-nasal Symptom Score (TNNSS), Rhinitis Quality of Life Questionnaire (RQLQ), serum chemokine Eotaxin, Inter Cellular Adhesion Molecule-1 (ICAM-1), and Eosinophil Cationic Protein (ECP). All adverse events will be evaluated during the trial. Conclusions This study will preliminarily evaluate if EA combined with Micro-Needle-Knife is effective and safe in the treatment of AR. Clinical trial registration https://clinicaltrials.gov/study/NCT06890260 ; identifier: NCT06890260.
BibTeX
@inproceedings{qiu2026efficacy,
  author = {Pengfei Qiu and Xue Wu and Ning Ye and Xiaofang Zhou and Jianfang Zhu and Xiayang Zeng},
  title = {{The efficacy of electroacupuncture combined with Micro-Needle-Knife for allergic rhinitis: study protocol for a randomized controlled trial}},
  booktitle = {Frontiers in Medicine},
  year = {2026},
  doi = {10.3389/fmed.2026.1756690},
}
Figure